Skip to main content

Table 2 Primary and secondary outcomes with data sources to investigate the impact of diagnostic and treatment procedures in patients with suspected UTI in human and veterinary primary care practices in Denmark

From: Exploring the feasibility and synergistic value of the One Health approach in clinical research: protocol for a prospective observational study of diagnostic pathways in human and canine patients with suspected urinary tract infection

General practice

Veterinary practice

Primary outcome

Source of data

Primary outcome

Source of data

Proportion of (i) appropriate decisions to treat with antibiotics and (ii) appropriate choices of antibiotic for each diagnostic path

Case report form

Proportion of (i) appropriate decisions to treat with antibiotics and (ii) appropriate choices of antibiotic for each diagnostic path

Case report form

Difference in the percentage of patients with appropriate antibiotic treatment when comparing diagnostic pathways during the consultation and diagnostic pathways after the consultation

Culture report from SSIa

Difference in the percentage of patients with appropriate antibiotic treatment when comparing diagnostic pathways during the consultation and diagnostic pathways after the consultation

Culture report from SVDa

Secondary outcomes

 

Secondary outcomes

 

Validity of each diagnostic path

Case report form

Validity of each diagnostic path

Case report form

Culture report from SSI

Culture report from SVD

Number of days until clinical cure (i.e., first day without symptoms from the urinary tract)

Symptom diary

Number of days until clinical cure (i.e., first day without clinical signs from the urinary tract

Symptom diary

Prevalence of uro-pathogens

Culture report from SSI

Prevalence of uro-pathogens

Culture report from SVD

Susceptibility patterns for each bacterial strain

Culture report from SSI

Susceptibility patterns for each bacterial strain

Culture report from SVD

Prevalence of ESBL-resistant E. coli

Culture report from SSI

Prevalence of multi-resistant bacterial strains

Culture report from SVD

Risk factors for harboring ESBL-resistant E. coli

Culture report from SSI

n.a.

n.a.

Patient questionnaire

  1. SSI Statens Serum Institute, SVD SUND VET DIAGNOSTIK, ESBL extended spectrum beta-lactamase, n.a. not available
  2. aReference laboratories